影像醫學科

Medicine and Dentistry

1. Hepatocellular Carcinoma 100%
2. Computer Assisted Tomography 66%
3. Positron Emission Tomography-Computed Tomography 42%
4. Embolization 39%
5. Transcatheter Arterial Chemoembolization 36%
6. Neoplasm 28%
7. Overall Survival 22%
8. Arterial Embolization 22%
9. Acute Pyelonephritis 18%
10. Breast Cancer 18%
11. Aortic Dissection 18%
12. Malignant Neoplasm 18%
13. Immune Checkpoint Inhibitor 16%
14. Succimer 15%
15. Tumor Thrombus 15%
16. Single-Photon Emission Computed Tomography 15%
17. positron emission tomographic scan 14%
18. Fluorodeoxyglucose F 18 14%
19. Epithelioma 13%
20. Mediastinal Tumor 13%
21. Deoxyglucose 13%
22. Glyceryl Trinitrate 13%
23. Non Small Cell Lung Cancer 13%
24. Radiomics 13%
25. Lipiodol 13%
26. Lymph Node Metastasis 12%
27. Radiation Therapy 12%
28. Doxorubicin 12%
29. Diseases 12%
30. Magnetic Resonance Imaging 12%
31. Metastatic Carcinoma 12%
32. Thorax Radiography 12%
33. Radioisotope 11%
34. Retrospective Study 11%
35. Fluorine-18 11%
36. Fluorodeoxyglucose 11%
37. Microsphere 10%
38. Musculoskeletal Pain 10%
39. Technetium-99 10%
40. Receptor 10%
41. Inferior Vena Cava 9%
42. Pediatrics 9%
43. Radioisotope Renography 9%
44. Venography 9%
45. Pulmonary Sequestration 9%
46. Dual Energy Computed Tomography 9%
47. Puncture 9%
48. Rib 9%
49. Segmentectomy 9%
50. Right Atrium 9%
51. Central Venous Catheter 9%
52. Superior Vena Cava 9%
53. Esophageal Squamous Cell Carcinoma 9%
54. Percutaneous Ethanol Injection 9%
55. Kidney Function 9%
56. Magnetic Resonance Cholangiopancreatography 9%
57. Heart Muscle Perfusion 9%
58. Appendix Perforation 9%
59. Proton Nuclear Magnetic Resonance 9%
60. Lung Tuberculosis 9%
61. Bleeding 9%
62. Standardized Uptake Value 8%
63. Gallium 67 8%
64. Bone Scintigraphy 8%
65. Iodine 123 8%
66. Volunteer 8%
67. Esophagus 8%
68. Kidney Scar 7%
69. Cancer Staging 7%
70. Cancer 7%
71. Multivariate Analysis 7%
72. Computed Tomography Angiography 7%
73. Child-Pugh Score 7%
74. Pelvis 7%
75. Adverse Event 7%
76. Transesophageal Echocardiography 7%
77. Thrombus 7%
78. Echography 7%
79. Chemoradiotherapy 7%
80. Diagnostic Accuracy 6%
81. False Positive Result 6%
82. Polyethylene Terephthalate 6%
83. Biopsy Technique 6%
84. Hazard Ratio 6%
85. Progression Free Survival 6%
86. Lymph Node 6%
87. Lung Tumor 6%
88. Disease Exacerbation 6%
89. Diagnostic Performance 6%
90. Computed Tomography Studies 6%
91. Musculoskeletal Tumor 6%
92. Propensity Score Matching 6%
93. Immunotherapy 5%
94. Liver Function 5%
95. Absorbable Gelatin Sponge 5%
96. Meta-Analysis 5%
97. Cholestasis 5%
98. Soft Tissue Tumor 5%
99. Bone Tissue 5%
100. Choline 5%

Keyphrases

1. Dopamine Transporter 32%
2. Single-photon Emission Computed Tomography (SPECT) 31%
3. Striatal Dopamine 23%
4. Serotonin Transporter 16%
5. Healthy Volunteers 9%
6. Taiwan 9%
7. Major Depressive Disorder 9%
8. Hepatocellular Carcinoma Treatment 9%
9. Family History 9%
10. F-18 9%
11. Mediastinal Tumor 9%
12. Superior Vena Cava 9%
13. Central Venous Catheter 9%
14. Point-based 9%
15. Right Atrium 9%
16. Dual-isotope SPECT 9%
17. Dopamine D2/3 Receptor 9%
18. Preoperative T Staging 9%
19. Surface Landmarks 9%
20. Alzheimer's Disease 9%
21. Serotonin Transporter Availability 8%
22. Drug-eluting Beads Transarterial Chemoembolization (DEB-TACE) 8%
23. 67Ga-citrate 7%
24. Transesophageal Echocardiography 7%
25. FDG PET-CT 6%
26. Lipiodol 6%
27. Chest CT 6%
28. 99mTc-TRODAT-1 6%
29. Dimercaptosuccinic Acid 6%
30. Unresectable Hepatocellular Carcinoma 5%
31. Iodobenzamide 5%
32. Euthymic Patients 5%
33. Surgical Risk 5%
34. Technetium-99m 5%
35. Conventional Transarterial Chemoembolization (cTACE) 5%
36. Midbrain 5%
37. Ga-67 5%
38. 123I 5%
39. Healthy Individuals 5%
40. Neoadjuvant Chemoradiotherapy (nCRT) 5%
41. Febrile Urinary Tract Infection 5%
42. Lymph Node Metastasis 5%
43. Palliative Treatment 5%